Insights into the unique functionality of inorganic micro/nanoparticles for versatile ultrasound theranostics

• Published in: Biomaterials Vol. 142; pp. 13 - 30
• Main Authors: Qian, Xiaoqin, Han, Xiaoxia, Chen, Yu
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.10.2017
• Subjects: Animals; Diagnostic Imaging; Humans; Inorganic biomaterials; Inorganic Chemicals - chemistry; Microbubbles; Nanomedicine; Nanoparticles - chemistry; Nanoparticles - ultrastructure; Theranostic Nanomedicine - methods; Theranostics; Ultrasonography; Ultrasound biomedicine; Microbubbles; Inorganic biomaterials; Ultrasound biomedicine; Theranostics; Nanomedicine
• ISSN: 0142-9612; 1878-5905
• DOI: 10.1016/j.biomaterials.2017.07.016

The clinical ultrasound (US)-based theranostic biomedicine suffers from the critical issue that traditional microbubbles (MBs) have lots of drawbacks such as low stability, large particle size, difficult structural control, etc. The unique composition, structure and functionality of inorganic micro/nanoplatforms have shown their great prospect for solving these critical issues and drawbacks of traditional organic MBs. This review summarizes and discusses the state-of-art development on exploring inorganic micro/nanoparticles for versatile US-based biomedical applications, ranging from US imaging, photoacoustic imaging, sonodynamic therapy, high intensity-focused US ablation and US-triggered chemotherapy. These inorganic micro/nanoplatforms include silica-based particles, Au, carbon nanotubes, TiO2, manganese oxide, iron oxide, Prussian blue, inorganic gas-generating nanoparticles and their versatile composite micro/nanosystems. Especially, their unique structure/composition-functionality relationships and biocompatibility/biosafety in US-based theranostics have been discussed and revealed in detail. Their facing challenges and future developments are finally discussed to promote their further clinical translations. It is highly expected that these inorganic micro/nanoplatforms will enter the clinical stage to benefit the personalized theranostics biomedicine based on their unique functionalities and high performance as necessarily required in US-based theranostics. [Display omitted]